A new drug based on decades of research at the University of Cambridge has today been approved by the National Institute for Health and Care Excellence (NICE) for use in people with relapsing-remitting multiple sclerosis. Lemtrada, manufactured by pharmaceutical company Genzyme, began life as Campath-1H, a drug developed out of research by Professor Herman Waldmann […]